Evidence map›Paper›PMID 38299827›Full record

ArticleInfection and immunity2024

Expression activation of over 70% of

Wurihan Wurihan, Yuxuan Wang, Sydney Yeung, Yi Zou, Zhao Lai, Joseph D Fondell, Wei Vivian Li, Guangming Zhong, Huizhou Fan

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The T3SS structural and effector genes ofFrontiers in cellular and infection microbiology · 2025
    Article
  5. Transcriptional profiling ofFrontiers in cellular and infection microbiology · 2025
    Article
  6. Chlamydiosis in Animals.Animals : an open access journal from MDPI · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Analyzing RNA-Seq Data frombioRxiv : the preprint server for biology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Wurihan WurihanDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.ORCID 0000-0001-7853-0130
Yuxuan WangDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.ORCID 0000-0003-0771-1078
Sydney YeungDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Yi ZouGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, Texas, USA.
Zhao LaiGreehey Children's Cancer Research Institute, University of Texas Health San Antonio, San Antonio, Texas, USA.
Joseph D FondellDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.ORCID 0000-0002-7046-9854
Wei Vivian LiDepartment of Statistics, University of California Riverside, Riverside, California, USA.ORCID 0000-0002-2087-2709
Guangming ZhongDepartment of Microbiology and Immunology, University of Texas Health San Antonio, San Antonio, Texas, USA.ORCID 0000-0001-7053-5009
Huizhou FanDepartment of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.ORCID 0000-0002-4903-926X
Rutgers, The State University of New Jersey · USThe University of Texas Health Science Center at San Antonio · USUniversity of California, Riverside · US

Funding

TISSUE CULTURE---COREP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Lei Zheng · 1991 to 2026
$59.1M
An oral vaccine against Chlamydia trachomatisU01AI182210 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GUANGMING ZHONG · 2024 to 2026
$6.5M
Novel Statistical Methods for Multiscale Analysis of Single-cell TranscriptomesR35GM142702 · NIGMS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI LI, WEI VIVIAN · 2021 to 2025
$1.6M
Illumina NovaSeq 6000 Sequencing SystemS10OD030311 · OD · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI LAI, ZHAO · 2021 to 2021
$600k
Chlamydia pathogenesisR56AI168279 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHONG, GUANGMING · 2022 to 2022
$571k
GrgA:a Multifunctional Transcription Factor that Control Chlamydial Gene ExpressionR21AI140167 · NIAID · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI FAN, HUIZHOU · 2019 to 2020
$435k
Exploration of SF3 as a Chemical Probe for Chlamydial BiologyR21AI154305 · NIAID · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI FAN, HUIZHOU · 2020 to 2021
$431k
NCI NIH HHS P30 CA054174NIAID NIH HHS R21 AI140167NIAID NIH HHS R21 AI154305NIAID NIH HHS R56 AI168279NIAID NIH HHS U01 AI182210NIGMS NIH HHS R35 GM142702NIH HHS S10 OD030311
6 · The paper itself

Abstract

The obligate intracellular bacterium

Indexed as

Chlamydia InfectionsChlamydia trachomatisBase SequenceCells, CulturedHumansReal-Time Polymerase Chain ReactionTranscriptomeChlamydiachlamydia developmental cyclegene regulationtranscriptiontranscriptome

Identifiers

PMID38299827
PMCPMC10929459
OpenAlexW4391449906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.